Pericytes are modified smooth muscle cells that closely enwrap small blood vessels, regulating and supporting the microvasculature through direct endothelial contact. Pericytes demonstrate a distinct immunohistochemical profile, including expression of αSMA (Smooth Muscle Actin), CD146, PDGFRβ (Platelet Derived Growth Factor Receptor β), and RGS5 (regulator of G-protein signaling 5). Previously, pericyte related antigens have been observed to be present among a group of soft tissue tumors with a perivascular growth pattern, including glomus tumor, myopericytoma and angioleiomyoma. Similarly, malignant tumor cells have been shown to pericyte-like immunoprofile when present in a perivascular location, seen in malignant melanoma, glioblastoma, and adenocarcinoma. Here, we examine well-differentiated liposarcoma specimens, which showed some element of perivascular areas with the appearance of smooth muscle (N=7 tumors). Immunohistochemical staining was performed for pericyte antigens, including αSMA, CD146, PDGFRβ, and RGS5. Results showed consistent pericytic marker expression among liposarcoma tumor cells within a perivascular distribution. MDM2 immunohistochemistry and fluorescence in situ hybridization for MDM2 revealed that these perivascular cells were of tumor origin (7/7 tumors), while double immunohistochemical detection for CD31/CD146 ruled out an endothelial cell contribution. These findings further support the concept of pericytic mimicry, already established in diverse malignancies, and its presence in well-differentiated liposarcoma. The extent to which pericytic mimicry has prognostic significance in liposarcoma is as yet unknown.
Introduction
Pericytes are modified smooth muscle cells that closely enwrap small blood vessels, regulating and supporting the microvasculature through direct endothelial contact. Pericytes demonstrate a distinct immunohistochemical profile, including expression of αSMA (Smooth Muscle Actin), CD146, PDGFRβ (Platelet Derived Growth Factor Receptor β), and RGS5 (regulator of G-protein signaling 5), without evidence of endothelial differentiation 1, 2 . Current interests in pericytes stem in large part from the growing understanding that this cell type represents a native mesenchymal stem cell (MSC) progenitor cell 1, [3] [4] [5] [6] [7] [8] [9] . Indeed, purified pericytes give rise to multiple mesodermal tissues after in vitro differentiation or in vivo transplantation, including bone, adipose, cartilage, and musclefeatures identical to traditionally derived bone marrow MSC 9, 10 .
Growing data suggests that when tumor cells adopt a perivascular location, they also adopt cell surface markers characteristic of pericytes. This phenomenon is best understood in malignant melanoma, where tumor cells adopt a perivascular migration pattern, or 'angiotropism' [11] [12] [13] . This perivascular invasion, also called extravascular migratory metastasis (EVMM), is an under recognized route of tumor spread, and associated with a poor prognosis in melanoma 13 . Similarly, in the malignant brain tumor glioblastoma, tumor cells adopt a pericyte-like location associated with perivascular invasion 14, 15 . In fact, using cell-tracking techniques, investigators have found that the majority of vessel-lining pericyte-like cells in glioblastoma are actually of tumor cell origin. Likewise, recent research suggests that pancreatic and prostatic adenocarcinoma exhibit perivascular invasion for regional spread, although this has been less well studied 16, 17 . In summary, pericyte marker expression, also termed 'pericyte mimicry' is a characteristic finding across all studied tumors with a perivascular tumor growth.
A subset of liposarcomas display heterologous differentiation, including smooth muscle, bone, and cartilage. Non-neoplastic adipose tissue is a rich source of pericytes [18] [19] [20] [21] [22] , and it is currently assumed that tissue resident MSC are the precursors for these heterologous components within liposarcoma. Of particular interest are areas with the appearance of smooth muscle within well-differentiated liposarcoma [23] [24] [25] [26] . Areas resembling smooth muscle often appear to arise from and radiate outwards from intratumoral blood vessels, usually in a multifocal fashion 23 . These perivascular proliferations house atypical stromal cells characteristic of liposarcoma, often within the vessel wall. Of note, these perivascular cells demonstrate immunoreactivity Smooth Muscle Actin (SMA) 23 , but a more thorough examination of pericyte markers has not yet been performed.
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ACCEPTED MANUSCRIPT Shen 4 Here, we examine well-differentiated liposarcoma specimens. We hypothesized that these perivascular areas with the appearance of smooth muscle would be associated with a pericyte immunophenotype, or 'pericytic mimicry,' within liposarcoma tumor cells.
Materials and Methods

Tissue Identification and Histology
Tumors were identified using a retrospective review of the pathology slide archives of the Department of Pathology 
Immunohistochemistry
Immunohistochemistry for pericyte markers was performed using the ABC method (Vectastain Elite ABC, Vector Laboratories, Burlingame, CA, USA) using DAB as the chromogen (ImmPACT DAB, Vector Laboratories).
Multiple antigens were detected by multiplexing the ABC method and DAB chromogen with an alkaline phosphatase polymer detection method (ImmPress-AP Polymer Detection, Anti-mouse IG, Vector Laboratories) and
Vector Red® chromogen (Vector Red® Alkaline Phosphatase Substrate, Vector Laboratories).
The following primary antibodies were used: monoclonal mouse anti-MDM2 (1/100, EMD Millipore), Mayer's hematoxylin was used as a nuclear counterstain (1/5, ABCAM) and slides were mounted using an aqueous media (VectaMount AQ, Vector Laboratories). In all cases, immunohistochemical staining without primary antibody was used as a negative control.
Fluorescence in situ hybridization (FISH)
Fluorescence in situ hybridization (FISH) was performed using commercially available fluorescently . As well as being in greater number, the amplified MDM2 signals were usually smaller and tightly clustered. Representative images of the perivascular areas were captured using a cooled charged coupled device camera.
Results
Perivascular smooth muscle proliferation in well-differentiated liposarcoma / atypical lipomatous tumor (WDLPS / ALT)
Seven cases of WDLPS / ALT with perivascular areas with the appearance of smooth muscle were identified in our retrospective examination of case files ( Table 1) The histologic appearance of the seven cases of WDLPS / ALT was first examined (Fig. 1) . Tumors showed a variable lipomatous to sclerotic background. Perivascular areas with the appearance of smooth muscle were most commonly in a multifocal distribution, often clustered around groups of adjacent blood vessels (black arrowheads, Fig. 1) . Enlarged, hyperchromatic and atypical stromal cells characteristic of liposarcoma were found within these perivascular areas (red arrowheads, Fig. 1) . These were seen both intimately associated with the endothelium and also at a distance from the vessel wall (compare Fig. 1F to 1E) . One case showed patchy heterologous bone formation (not shown).
Pericyte marker expression in liposarcoma / atypical lipomatous tumor (WDLPS / ALT)
Next, pericyte marker expression was evaluated by immunohistochemical stainings. First, perivascular areas were examined (Fig. 2 , three representative areas in different tumors shown). In each instance, atypical stromal cells were seen within a perivascular location. Interestingly, these atypical stromal cells were found to be frequently positive for the majority of pericyte antigens ( Fig. 2D-L, black arrowheads) . This included consistent immunoreactivity for αSMA, CD146, and RGS5. Of note, PDGFRβ showed minimal staining in most cases (not shown).
Next, areas within the tumor substance and apart from prominent vasculature were examined (Fig. 3) . For the most part, pericyte antigens were not commonly seen among lipoblasts or enlarged stromal cells within WDLPS / ALT apart from the perivascular areas. However, on detailed examination, rare to scattered atypical stromal cells were seen with pan-positivity for pericyte markers (αSMA, CD146, RGS5, and PDGFRβ shown, black arrowheads).
Confirmation of tumor cell origin among perivascular cells
Nuclear enlargement and hyperchromasia among perivascular cells has previously led to the assumption that these were of tumor cell origin 23 . In order to confirm this, markers of endothelial differentiation (CD31) and
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ACCEPTED MANUSCRIPT Shen 7 liposarcomatous origin (MDM2 gene amplification and MDM2 expression by IHC) were assayed (Fig. 4) . First, dual immunohistochemistry was performed for CD31 (highlighting endothelium red) and CD146 (highlighting perivascular cells in brown) (Fig. 4A,B) . As expected CD31 immunostaining was restricted to the endothelium, while CD146 highlighted both perivascular and endothelial cells. Next, MDM2 amplification within perivascular cells was assayed by fluorescence in situ hybridization (Fig. 4C,D) . A marked increase in MDM2 signals (red) was observed among perivascular tumor cells (vascular lumen highlighted with dashed white lines). These findings were confirmed with MDM2 immunohistochemical staining, demonstrating atypical perivascular cells with nuclear MDM2 immunoreactivity (Fig. 4E,F) . In aggregate, these studies confirm the tumor cell origin of perivascular cells with pericyte antigen expression in WDLPS / ALT.
Discussion
In summary, pericyte antigen expression is present among WDLPS / ALT tumor cells and is found predominantly in a perivascular distribution. Scattered single atypical stromal cells unassociated with vascular smooth muscle proliferation also showed pericyte antigen expression, albeit less frequently. The presence of multiple pericyte antigens among these vasculature-associated atypical stromal cells has strong parallels to pericytic mimicry, a phenomenon best described in malignant melanoma [11] [12] [13] 27 . Pericytic mimicry has also been termed extravascular migratory metastasis (EVMM) or angiotropism. In general, angiotropic tumor cells are defined histologically as tumor cells closely associated with the endothelium of vascular channels in a pericytic location, and do not show intravasation into the blood vessel. While in melanoma, pericytic mimicry is generally described at the advancing front of the tumor, in WDLPS / ALT this phenomenon was observed in a multicentric fashion in association with the vasculature.
Pericytic mimicry has been shown to be an independent poor prognostic marker in melanoma 13 .
Specifically, analysis of 52 patients with malignant melanoma showed a significant association between angiotropism and development of metastasis, with other prognostic features such as tumor thickness being identical.
Although somewhat limited in number, our cases followed a typical disease course for WDLPS / ALT, characterized by local recurrence in 2/7 cases (28.5%). Of note, Gronchi et al. recently found that myogenic differentiation was associated with a poor prognosis in retroperitoneal liposarcoma 28 . However this study examined both well-
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT Shen 8 differentiated and dedifferentiated tumors, and included both markers of smooth and skeletal muscle differentiation.
Thus, we consider this 'myogenic differentiation' wholly distinct from pericytic mimicry.
In our previous reports, we examined pericyte antigen expression among soft tissue tumors with a perivascular growth pattern 29, 30 . These included glomus tumor, myopericytoma, and angioleiomyoma. Results showed that among all tumors a consistent expression pattern of pericyte markers was observed in relation to their perivascular pattern of growth, including diffuse immunoreactivity for αSMA, CD146, and PDGFRβ. Later studies found that angiomyolipoma and related PEComa family tumors showed relatively consistent, although patchy, pericytic marker expression 30 . These expression patterns are distinct from the predominantly perivascular distribution of pericyte antigens in WDLPS / ALT.
Unfortunately, no known pericytic markers are absolutely specific. For example, RGS5 expression has been observed in a number of malignancies, including lung 31 , gastric 32 , and hepatocellular carcinomas 33 , as well as various lymphomas 33 . Likewise, CD146 expression can be found in mucoepidermoid carcinoma, gestational trophoblastic tumors, angiosarcoma, and Kaposi's sarcoma, among other tumor types 34 . However, based on the available literature and the present study, co-expression of multiple pericyte markers (including αSMA, CD146, PDGFRβ, and RGS5) is quite specific for pericytic differentiation. Other possible pericyte markers have yet to be investigated in soft tissue tumors, including Ang-1, Ang-2 35 , and Nestin 36, 37 .
In summary, pericyte antigen expression is present among WDLPS / ALT tumor cells and is found predominantly in a perivascular distribution. This phenomenon parallels pericyte mimicry, found in melanoma and other malignant neoplasms. The extent to which pericytic mimicry has prognostic significance in liposarcoma is as yet unknown.
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